Further clinical interpretation and implications of KEYNOTE-048 findings - Authors' reply

Affiliations

¹ Department of Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520-8028, USA. Electronic address: barbara.burtness@yale.edu.
² Biostatistics and Research Decision Sciences, Merck & Co., Kenilworth, NJ, USA.
³ The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, UK.
⁴ Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; University of Melbourne, Melbourne, VIC, Australia.

Comment

Barbara Burtness et al. Lancet. 2020.

. 2020 Aug 8;396(10248):379-380.

doi: 10.1016/S0140-6736(20)30900-4.

¹ Department of Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520-8028, USA. Electronic address: barbara.burtness@yale.edu.
² Biostatistics and Research Decision Sciences, Merck & Co., Kenilworth, NJ, USA.
³ The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, UK.
⁴ Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; University of Melbourne, Melbourne, VIC, Australia.

No abstract available

Comment on

Recurrence of breast cancer after anaesthesia.
Nielsen KC, Melton MS, Gebhard RE, Greengrass RA. Nielsen KC, et al. Lancet. 2020 Aug 8;396(10248):376. doi: 10.1016/S0140-6736(20)30487-6. Lancet. 2020. PMID: 32771098 No abstract available.
Recurrence of breast cancer after anaesthesia.
Moris D, Kontos M. Moris D, et al. Lancet. 2020 Aug 8;396(10248):376-377. doi: 10.1016/S0140-6736(20)30489-X. Lancet. 2020. PMID: 32771099 No abstract available.
Further clinical interpretation and implications of KEYNOTE-048 findings.
Szturz P, Vermorken JB. Szturz P, et al. Lancet. 2020 Aug 8;396(10248):379. doi: 10.1016/S0140-6736(20)30907-7. Lancet. 2020. PMID: 32771103 No abstract available.